Edge Therapeutics, Inc. Stock Agreements
4 Contracts & Agreements
- Common Stock Purchase Agreement, dated July 29, 2019 between PDS Biotechnology Corporation and Aspire Capital Fund, LLC (Filed With SEC on July 30, 2019)
- Form of Stock Option Grant Notice and Stock Option Agreement under the 2019 Inducement Plan (Filed With SEC on June 20, 2019)
- Form of Employee Stock Option Agreement (Filed With SEC on March 2, 2017)
- Form of Executive Stock Option Agreement (Filed With SEC on March 2, 2017)
